Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
about
Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition.Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study."Combination-oriented molecular-targeting prevention" of cancer: a model involving the combination of TRAIL and a DR5 inducer.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized.
P2860
Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Anti-gout agent allopurinol ex ...... ted apoptosis-inducing ligand.
@en
Anti-gout agent allopurinol ex ...... ted apoptosis-inducing ligand.
@nl
type
label
Anti-gout agent allopurinol ex ...... ted apoptosis-inducing ligand.
@en
Anti-gout agent allopurinol ex ...... ted apoptosis-inducing ligand.
@nl
prefLabel
Anti-gout agent allopurinol ex ...... ted apoptosis-inducing ligand.
@en
Anti-gout agent allopurinol ex ...... ted apoptosis-inducing ligand.
@nl
P2093
P1476
Anti-gout agent allopurinol ex ...... ted apoptosis-inducing ligand.
@en
P2093
Kimihiro Yano
Mano Horinaka
Miki Wakada
Takashi Yasuda
Takumi Shiraishi
Tatsushi Yoshida
Toshiyuki Sakai
Tsuneharu Miki
Yoichi Mizutani
P304
P356
10.1158/1541-7786.MCR-08-0012
P50
P577
2008-12-01T00:00:00Z